Literature DB >> 3180416

HPLC measurement of phenylalanine in plasma.

N D Atherton1, A Green.   

Abstract

Measurement of phenylalanine in plasma is required for the diagnosis and subsequent dietary management of phenylketonuria (PKU). We have developed an isocratic high-performance liquid-chromatographic (HPLC) method, with ultraviolet detection. For this measurement 10 microL of plasma is needed, and the complete analysis can be done in less than 15 min. Interbatch coefficients of variation for human plasma samples (phenylalanine 136-1541 mumol/L) ranged between 2.2% and 4.4%. The method has a wide linear range (10-3500 mumol/L), and results (y) correlated well with those (x) of an ion-exchange chromatographic method (r = 0.996; y = 1.014 x - 11.9; n = 64, range 22-1823 mumol/L). Only standard HPLC equipment is needed and no specialized sample preparation or detection system is required. The procedure has proved robust and reliable in regular routine use.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180416

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion.

Authors:  N Takamatsu; L S Welage; N M Idkaidek; D Y Liu; P I Lee; Y Hayashi; J K Rhie; H Lennernäs; J L Barnett; V P Shah; L Lesko; G L Amidon
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

2.  Relationship between plasma and red cell biopterins in acute and chronic hyperphenylalaninaemia.

Authors:  R J Leeming; S K Hall; I M Surplice; A Green
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet.

Authors:  A MacDonald; G Rylance; S K Hall; D Asplin; I W Booth
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

4.  Effect of growth hormone on tumor and host in an animal model.

Authors:  R F Wolf; B Ng; B Weksler; M Burt; M F Brennan
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

5.  Reduction of L-phenylalanine in protein hydrolysates using L-phenylalanine ammonia-lyase from Rhodosporidium toruloides.

Authors:  María Teresita Castañeda; Osao Adachi; Roque Alberto Hours
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-05       Impact factor: 3.346

6.  Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients.

Authors:  R F Wolf; D B Pearlstone; E Newman; M J Heslin; A Gonenne; M E Burt; M F Brennan
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

7.  Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches.

Authors:  D Hussein; A Starr; L Heikal; E McNeill; K M Channon; P R Brown; B J Sutton; J M McDonnell; M Nandi
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

8.  Free use of fruits and vegetables in phenylketonuria.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

9.  Administration of protein substitute and quality of control in phenylketonuria: a randomized study.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

10.  l-Phenylalanine Restores Vascular Function in Spontaneously Hypertensive Rats Through Activation of the GCH1-GFRP Complex.

Authors:  Lamia Heikal; Anna Starr; Dania Hussein; Jesus Prieto-Lloret; Phil Aaronson; Lea Ann Dailey; Manasi Nandi
Journal:  JACC Basic Transl Sci       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.